206 related articles for article (PubMed ID: 18391696)
21. A mechanism for unsplicing and exon skipping in human alpha- and beta-globin mutant pre-mRNA splicing.
Iida Y
Nucleic Acids Symp Ser; 1997; (37):183-4. PubMed ID: 9586060
[TBL] [Abstract][Full Text] [Related]
22. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.
El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A
Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanism of beta-thalassaemia caused by 22-bp duplication.
Svasti S; Boonchoy C; Vanichsetakul P; Winichagoon P; Fucharoen S
Ann Hematol; 2008 Aug; 87(8):633-7. PubMed ID: 18392622
[TBL] [Abstract][Full Text] [Related]
24. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
Traeger-Synodinos J; Papassotiriou I; Metaxotou-Mavrommati A; Vrettou C; Stamoulakatou A; Kanavakis E
Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
[TBL] [Abstract][Full Text] [Related]
25. Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations.
Suter D; Tomasini R; Reber U; Gorman L; Kole R; Schümperli D
Hum Mol Genet; 1999 Dec; 8(13):2415-23. PubMed ID: 10556289
[TBL] [Abstract][Full Text] [Related]
26. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
27. RNA modulation, repair and remodeling by splice switching oligonucleotides.
Kole R; Williams T; Cohen L
Acta Biochim Pol; 2004; 51(2):373-8. PubMed ID: 15218534
[TBL] [Abstract][Full Text] [Related]
28. Temperature-dependent splicing of beta-globin pre-mRNA.
Gemignani F; Sazani P; Morcos P; Kole R
Nucleic Acids Res; 2002 Nov; 30(21):4592-8. PubMed ID: 12409448
[TBL] [Abstract][Full Text] [Related]
29. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
30. Quantification analysis of splice signal sequences. Exon skipping in beta-globin gene of thalassemia.
Iida Y
Nucleic Acids Symp Ser; 1993; (29):161-2. PubMed ID: 8247751
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.
Kang SH; Cho MJ; Kole R
Biochemistry; 1998 May; 37(18):6235-9. PubMed ID: 9572837
[TBL] [Abstract][Full Text] [Related]
32. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
33. RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice.
Svasti S; Suwanmanee T; Fucharoen S; Moulton HM; Nelson MH; Maeda N; Smithies O; Kole R
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1205-10. PubMed ID: 19164558
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of thalassemia in southeast Asia.
Winichagoon P; Fucharoen S; Wilairat P; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():235-40. PubMed ID: 8629113
[TBL] [Abstract][Full Text] [Related]
35. Novel beta-thalassemia trait (IVS I-1 G-->C) in a Japanese family.
Fujihara N; Tozuka M; Ueno I; Yamauchi K; Nakagoshi R; Ishikawa S; Hirota M; Okumura N; Ishii E; Katsuyama T
Am J Hematol; 2003 Jan; 72(1):64-6. PubMed ID: 12508270
[TBL] [Abstract][Full Text] [Related]
36. Antisense oligonucleotides as modulators of pre-mRNA splicing.
Sierakowska H; Agrawal S; Kole R
Methods Mol Biol; 2000; 133():223-33. PubMed ID: 10561842
[No Abstract] [Full Text] [Related]
37. Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.
Phanthong P; Borwornpinyo S; Kitiyanant N; Jearawiriyapaisarn N; Nuntakarn L; Saetan J; Nualkaew T; Sa-Ngiamsuntorn K; Anurathapan U; Dinnyes A; Kitiyanant Y; Hongeng S
Stem Cells Transl Med; 2017 Apr; 6(4):1059-1069. PubMed ID: 28213976
[TBL] [Abstract][Full Text] [Related]
38. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
39. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
Marquis J; Kämpfer SS; Angehrn L; Schümperli D
Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
[TBL] [Abstract][Full Text] [Related]
40. Thalassemia intermedia due to a novel mutation in the second intervening sequence of the beta-globin gene.
Agouti I; Bennani M; Ahmed A; Barakat A; Mohamed K; Badens C
Hemoglobin; 2007; 31(4):433-8. PubMed ID: 17994377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]